In this article, we will discuss the 5 best SPACs to buy according to Herb Wagner’s FinePoint Capital. If you want to read our detailed analysis of the SPAC industry, go directly to the 10 Best SPACs to Buy According to Herb Wagner’s FinePoint Capital.
5. Dragoneer Growth Opportunities Corp. III (NASDAQ: DGNU)
Wagner’s Stake Value: $18,494,000
Percentage of Herb Wagner’s 13F Portfolio: 3.46%
Dragoneer Growth Opportunities Corp. III (NASDAQ: DGNU) is a special purpose acquisition company based in San Francisco, California. It was incorporated in 2020 and stands fifth on the list of 10 best SPACs to buy according to Herb Wagner’s FinePoint Capital.
Dragoneer Growth Opportunities Corp. III (NASDAQ: DGNU) went public in March 2021 and raised more than $400 million from the offering. On August 18, Dragoneer Growth Opportunities Corp. III (NASDAQ: DGNU) posted earnings for the second quarter of 2021. It reported a net loss per share of $0.38 and a net loss per share of $1.01 for the first six months of 2021.
The hedge fund chaired by Herb Wagner owns more than 1.85 million shares in Dragoneer Growth Opportunities Corp. III (NASDAQ: DGNU), worth over $18.49 million, representing 3.46% of their investment portfolio. Maverick Capital is the most significant stakeholder in Dragoneer Growth Opportunities Corp. III (NASDAQ: DGNU) out of the 873 hedge funds tracked by Insider Monkey in the second quarter of 2021. The hedge fund owns 3 million shares of the company worth $30 million.
4. Fortress Value Acquisition Corp. IV (NYSE: FVIV)
Wagner’s Stake Value: $18,531,000
Percentage of Herb Wagner’s 13F Portfolio: 3.47%
Fortress Value Acquisition Corp. IV (NYSE: FVIV) collaborates with one or more companies to accomplish a merger, capital stock exchange, asset purchase, stock purchase, reorganization, or related business combination. The company was incorporated in 2020 and is ranked fourth on the list of 10 best SPACs to buy according to Herb Wagner’s FinePoint Capital. Fortress Value Acquisition Corp. IV (NYSE: FVIV) presently has a $19.1 billion market capitalization. The CEO of the company is Joshua A.
On August 9, Fortress Capital Acquisition Corp. (NYSE: FCAX) reported earnings for the second quarter of 2021. It reported earnings per share of $0.39, and earnings per share of $0.40 for the first six months of 2021.
FinePoint Capital holds 1.85 million shares in Fortress Capital Acquisition Corp. (NYSE: FCAX), worth over $18.53 million. This represents 3.47% of their portfolio. Alec Litowitz And Ross Laser’s Magnetar Capital is a leading shareholder in Fortress Capital Acquisition Corp. (NYSE: FCAX), with 4.01 million shares worth more than $40.14 million.
3. Fortress Capital Acquisition Corp. (NYSE: FCAX)
Wagner’s Stake Value: $18,569,000
Percentage of Herb Wagner’s 13F Portfolio: 3.48%
Fortress Capital Acquisition Corp. (NYSE: FCAX) is a blank check corporation formed to accomplish a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combinations with one or more firms. It was founded in 2020 and is placed third on the list of 10 best SPACs to buy according to Herb Wagner’s FinePoint Capital. Fortress Capital Acquisition Corp. (NYSE: FCAX) presently has a market capitalization of $485 million.
Fortress Capital Acquisition Corp. (NYSE: FCAX) raised $350 million from IPO-related proceeds in January 2021. The Chief Executive Officer and Chairman of the firm is Michael Nierenberg. On August 9, Fortress Capital Acquisition Corp. (NYSE: FCAX) declared earnings for the second quarter of 2021. It posted earnings per share of $0.10, and earnings per share of $0.27 for the first six months of 2021.
The hedge fund chaired by Herb Wagner holds 1.89 million shares in Fortress Capital Acquisition Corp. (NYSE: FCAX) worth over $18.57 million. Empyrean Capital Partners is the biggest stakeholder in Fortress Capital Acquisition Corp. (NYSE: FCAX), with 3.11 million shares worth $31.16 million.
2. Revolution Healthcare Acquisition Corp. (NASDAQ: REVH)
Wagner’s Stake Value: $18,587,000
Percentage of Herb Wagner’s 13F Portfolio: 3.48%
Revolution Healthcare Acquisition Corp. (NASDAQ: REVH) is looking for acquisition possibilities in the healthcare, life sciences, and technology industries. The company was incorporated in 2021 and is ranked second on the list of 10 best SPACs to buy according to Herb Wagner’s FinePoint Capital. Revolution Healthcare Acquisition Corp. (NASDAQ: REVH) has a market capitalization of 559.598 million. The 52-week price range of the stock is between $9.50 – $10.70.
Revolution Healthcare Acquisition Corp. (NASDAQ: REVH) went public in March 2021, managing to raise close to $500 million from the initial offering. On August 9, Revolution Healthcare Acquisition Corp. (NASDAQ: REVH) announced earnings for the second quarter of 2021. It reported earnings per share of $7.00, compared to the earnings per share of $2.59 for the first six months of 2021.
Revolution Healthcare Acquisition Corp. (NASDAQ: REVH) is the latest addition in Herb Wagner’s hedge fund portfolio, as FinePoint Capital bought 1.84 million shares of the company, worth $18.59 million.
1. Reinvent Technology Partners Y (NASDAQ: RTPY)
Wagner’s Stake Value: $19,417,000
Percentage of Herb Wagner’s 13F Portfolio: 3.64%
Reinvent Technology Partners Y (NASDAQ: RTPY) enters into a capital stock exchange, stock purchase, reorganization, asset acquisition, or related business combination with one or more businesses or entities. The company was founded in 2020 and is placed first on the list of 10 best SPACs to buy according to Herb Wagner’s FinePoint Capital. Reinvent Technology Partners Y (NASDAQ: RTPY) currently has a market capitalization of $1.21 billion.
It was one of the first corporate software firms to use a subscription-based business model when it went public in 2000. On July 15, Aurora, a self-driving technology firm, agreed to combine with Reinvent Technology Partners Y (NASDAQ: RTPY) in a SPAC agreement.
The stock is a new arrival on Herb Wagner’s portfolio, as his hedge fund bought about 1.92 million shares of Reinvent Technology Partners Y (NASDAQ: RTPY), worth $19.42 million. In addition, Seth Klarman’s Baupost Group is a leading shareholder in Reinvent Technology Partners Y (NASDAQ: RTPY), with 6 million shares worth more than $59.34 million.
You can also take a peek at 10 Best SPACs to Buy According to David Einhorn’s Greenlight Capital and 10 Best SPACs to Invest In According to Reddit
